Insider trading

Period: 120 months Stock: ONC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

455 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

455 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

455 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

455 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
455 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
455 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

455 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
20 Jul 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 7×
$7.24M 28,762 at 251.85
100%
Sold half or more
20 Jul 2020
Wang Xiaodong Director · indirect
Sold, plan not stated 5×
$3.02M 12,000 at 251.31
100%
Sold half or more
20 Jul 2020
Wang Xiaodong Director
Sold, plan not stated 5×
$1.26M 5,000 at 251.98
100%
Sold half or more
20 Jul 2020
Wu Xiaobin President & GM China
Sold, plan not stated
$650.41K 2,600 at 250.16
100%
Sold half or more
17 Jul 2020
Wu Xiaobin President & GM China
Sold, plan not stated 2×
$172.02K 700 at 245.74
100%
Sold half or more
15 Jul 2020
Wu Xiaobin President & GM China
Sold, plan not stated 4×
$651.00K 2,700 at 241.11
100%
Sold half or more
13 Jul 2020
Wu Xiaobin President & GM China
Sold, plan not stated
$660.00K 3,000 at 220.00
100%
Sold half or more
8 Jul 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 7×
$3.53M 17,529 at 201.39
100%
Sold half or more
7 Jul 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 4×
$3.78M 19,023 at 198.86
100%
Sold half or more
7 Jul 2020
Wang Xiaodong Director · indirect
Sold, plan not stated
$1.20M 6,000 at 200.00
100%
Sold half or more
7 Jul 2020
Huang Jane CMO, Hematology
Sold, plan not stated
$784.20K 3,921 at 200.00
100%
Sold half or more
6 Jul 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 4×
$3.42M 17,362 at 197.11
100%
Sold half or more
1 Jul 2020
Wang Xiaodong Director
Sold, plan not stated 4×
$924.57K 4,847 at 190.75
100%
Sold half or more
1 Jul 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 2×
$731.02K 3,816 at 191.57
100%
Sold half or more
29 Jun 2020
Huang Jane CMO, Hematology
Sold, plan not stated 6×
$369.25K 1,935 at 190.83
100%
Sold half or more
29 Jun 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 3×
$276.37K 1,435 at 192.60
100%
Sold half or more
29 Jun 2020
Liang Howard CFO & Chief Strategy Officer
Sold, plan not stated
$57.37K 300 at 191.23
100%
Sold half or more
26 Jun 2020
Huang Jane CMO, Hematology
Sold, plan not stated 3×
$416.40K 2,079 at 200.29
100%
Sold half or more
24 Jun 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 4×
$2.69M 14,381 at 187.34
100%
Sold half or more
23 Jun 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 5×
$2.82M 15,070 at 186.88
51.2%
Sold half or more
23 Jun 2020
Wang Xiaodong Director · indirect
Sold, plan not stated 3×
$1.12M 6,000 at 186.38
100%
Sold half or more
22 Jun 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 5×
$1.88M 10,281 at 182.43
25.9%
22 Jun 2020
Wang Xiaodong Director
Sold, plan not stated 4×
$906.67K 5,000 at 181.33
100%
Sold half or more
10 Jun 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$157.56K 900 at 175.07
100%
Sold half or more
8 Jun 2020
Wang Xiaodong Director
Sold, plan not stated 3×
$1.03M 6,000 at 170.91
100%
Sold half or more
8 Jun 2020
Wu Xiaobin President & GM China
Sold, plan not stated 3×
$478.32K 2,800 at 170.83
100%
Sold half or more
8 Jun 2020
Huang Jane CMO, Hematology
Sold, plan not stated
$107.80K 631 at 170.84
100%
Sold half or more
8 Jun 2020
Liang Howard CFO & Chief Strategy Officer
Sold, plan not stated
$77.39K 453 at 170.84
100%
Sold half or more
29 May 2020
Huang Jane CMO, Hematology
Sold, plan not stated 3×
$245.78K 1,500 at 163.86
100%
Sold half or more
19 May 2020
Glazer Donald W. Director
Sold, plan not stated
$1.70M 10,000 at 169.84
100%
Sold half or more
1 May 2020
Wu Xiaobin President & GM China
Sold, plan not stated 4×
$992.71K 7,024 at 141.33
100%
Sold half or more
1 May 2020
OYLER JOHN Chief Executive Officer
Sold, plan not stated 4×
$655.54K 4,635 at 141.43
100%
Sold half or more
29 Apr 2020
Huang Jane CMO, Hematology
Sold, plan not stated
$243.45K 1,500 at 162.30
100%
Sold half or more
16 Apr 2020
Huang Jane CMO, Hematology
Sold, plan not stated
$240.00K 1,500 at 160.00
100%
Sold half or more
4 Mar 2020
Wang Xiaodong Director
Sold, plan not stated 3×
$785.68K 5,000 at 157.14
100%
Sold half or more
18 Feb 2020
Huang Jane CMO, Hematology
Sold, plan not stated 2×
$255.38K 1,500 at 170.25
100%
Sold half or more
21 Jan 2020
Huang Jane CMO, Hematology
Sold, plan not stated 3×
$256.04K 1,500 at 170.69
100%
Sold half or more
17 Dec 2019
OYLER JOHN Chief Executive Officer
Sold, plan not stated 7×
$10.00M 62,259 at 160.62
100%
Sold half or more
16 Dec 2019
Huang Jane CMO, Hematology
Sold, plan not stated 7×
$247.71K 1,500 at 165.14
100%
Sold half or more
18 Nov 2019
Liang Howard CFO & Chief Strategy Officer
Sold, plan not stated 8×
$4.86M 25,000 at 194.34
100%
Sold half or more
18 Nov 2019
Huang Jane CMO, Hematology
Sold, plan not stated 5×
$291.74K 1,500 at 194.49
100%
Sold half or more
15 Nov 2019
Wang Xiaodong Director
Sold, plan not stated
$302.27K 1,496 at 202.05
100%
Sold half or more
15 Nov 2019
Wu Xiaobin President & GM China
Sold, plan not stated
$202.05K 1,000 at 202.05
100%
Sold half or more
15 Nov 2019
Wang Xiaodong Director · indirect
Sold, plan not stated
$79.81K 395 at 202.05
100%
Sold half or more
14 Nov 2019
Wang Xiaodong Director
Sold, plan not stated 7×
$1.64M 8,504 at 193.31
85.0%
Sold half or more
14 Nov 2019
Wang Xiaodong Director · indirect
Sold, plan not stated
$504.24K 2,605 at 193.57
86.8%
Sold half or more
5 Nov 2019
Sold, plan not stated 4×
$718.77K 3,800 at 189.15
95.0%
Sold half or more
4 Nov 2019
Huang Jane CMO, Hematology
Sold, plan not stated 5×
$6.27M 32,900 at 190.46
100%
Sold half or more
4 Nov 2019
Sold, plan not stated 5×
$800.07K 4,200 at 190.49
100%
Sold half or more
4 Nov 2019
Wang Xiaodong Director
Sold, plan not stated
$190.00K 1,000 at 190.00
100%
Sold half or more
Showing 301–350 of 455. ← Newer Page 7 of 10 Older →